Nath Bio-Genes (India) (NATHBIOGEN) — Financial Results

Nath Bio-Genes reported FY26 revenue of ₹4,316 million, up 19% YoY, with PAT at ₹384 million and EPS of [amount context mismatch]. EBITDA reached [amount context mismatch] million (12% margin), while gross margin held at 56%. International revenue is targeted at 10-15% of total, contributing INR 150 crores against a projected INR 1,000 crore top line. FY27 revenue growth is expected at 15-20%, driven by 22% cotton volume growth and expansion in paddy and maize. Management highlighted inventory adjustments affecting cash flow and a rising effective tax rate of 11% due to marketing expenses.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NATHBIOGEN ✨ Ask AI About This

About Nath Bio-Genes (India) Limited (NATHBIOGEN)

Fast Moving Consumer Goods · FMCG · Listed on NSE

Market Cap: ₹289.43 Cr P/E: 7.8 ROE: 6.0% ROCE: 7.9% Div Yield: 1.31%

View full NATHBIOGEN stock details →

📡 Get AI alerts when NATHBIOGEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NATHBIOGEN — Free

💡 Ask AI about this filing

"How does this financial results affect Nath Bio-Genes (India) Limited's outlook?" "What did Nath Bio-Genes (India) Limited announce on 11 May 2026?" "Is this positive or negative for NATHBIOGEN?"

Ask AI Free →

📊 More NATHBIOGEN filings

See all NATHBIOGEN filings →

🔥 Also filed on 11 May 2026

PRIVISCL Privi Speciality Chemicals Limited Financial Results PREMIERENE Premier Energies Limited Announcement PRIVISCL Privi Speciality Chemicals Limited Financial Results PRIVISCL Privi Speciality Chemicals Limited Corporate Action PRIVISCL Privi Speciality Chemicals Limited Corporate Action PUNJABCHEM Punjab Chemicals & Crop Protection Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NATHBIOGEN files new disclosures

Track NATHBIOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NATHBIOGEN — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd